Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

Investigators sought to determine the effect of “Smart PSA” guidelines on screening behavior and biopsy outcomes among Black men.

For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

A new study co-led by WEHI has found a simple blood test can help identify the early-stage testicular cancer patients who are ...

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...